T1	Participants 153 236	individuals with serious mental illness (SMI) receiving antipsychotic drug therapy.
T2	Participants 479 499	individuals with SMI
T3	Participants 521 554	30 individuals (BMI â‰¥ 28 kg/m(2))
T4	Participants 1331 1373	patients taking antipsychotic medications;